TherapeuticsMD, Inc. (TXMD)
2.21
-0.03
(-1.34%)
USD |
NASDAQ |
Sep 04, 16:00
2.17
-0.04
(-1.81%)
After-Hours: 20:00
TherapeuticsMD Net Income (Quarterly) : 0.164M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.164M |
| March 31, 2026 | 0.103M |
| December 31, 2025 | -0.612M |
| September 30, 2025 | 0.05M |
| June 30, 2025 | 0.545M |
| March 31, 2025 | -0.636M |
| December 31, 2024 | 0.114M |
| September 30, 2024 | -0.567M |
| June 30, 2024 | -1.05M |
| March 31, 2024 | -0.809M |
| December 31, 2023 | -1.541M |
| September 30, 2023 | -1.434M |
| June 30, 2023 | -2.414M |
| March 31, 2023 | -2.31M |
| September 30, 2022 | -14.63M |
| June 30, 2022 | -14.87M |
| March 31, 2022 | -17.88M |
| December 31, 2021 | -42.96M |
| September 30, 2021 | -47.42M |
| June 30, 2021 | -42.65M |
| March 31, 2021 | -39.38M |
| December 31, 2020 | -42.09M |
| September 30, 2020 | -32.61M |
| June 30, 2020 | -51.98M |
| March 31, 2020 | -56.85M |
| Date | Value |
|---|---|
| December 31, 2019 | -49.44M |
| September 30, 2019 | -31.97M |
| June 30, 2019 | -55.24M |
| March 31, 2019 | -39.51M |
| December 31, 2018 | -39.39M |
| September 30, 2018 | -35.61M |
| June 30, 2018 | -33.22M |
| March 31, 2018 | -24.40M |
| December 31, 2017 | -21.43M |
| September 30, 2017 | -14.66M |
| June 30, 2017 | -19.68M |
| March 31, 2017 | -21.16M |
| December 31, 2016 | -22.84M |
| September 30, 2016 | -25.02M |
| June 30, 2016 | -21.09M |
| March 31, 2016 | -20.93M |
| December 31, 2015 | -17.48M |
| September 30, 2015 | -19.47M |
| June 30, 2015 | -27.23M |
| March 31, 2015 | -20.89M |
| December 31, 2014 | -16.30M |
| September 30, 2014 | -17.83M |
| June 30, 2014 | -10.90M |
| March 31, 2014 | -9.183M |
| December 31, 2013 | -8.379M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.869M |
| Total Expenses (Quarterly) | 0.705M |
| EPS Diluted (Quarterly) | 0.0133 |
| Enterprise Value | 21.95M |
| Gross Profit Margin (Quarterly) | 62.14% |
| Profit Margin (Quarterly) | 18.87% |
| Earnings Yield | -0.86% |
| Normalized Earnings Yield | -0.5792 |